Data gathered: December 21
AI Stock Analysis - Ginkgo Bioworks Holdings (DNA)
Analysis generated December 3, 2024. Powered by Chat GPT.
Ginkgo Bioworks Holdings is a biotechnology company that specializes in using bioengineering to develop organism-based synthetic biology. The company engineers and produces custom organisms for applications across a wide array of industries, including agriculture, pharmaceuticals, and energy. Their objective is to make biology easier to engineer and bring to market.
Stock Alerts - Ginkgo Bioworks Holdings (DNA)
 |
Ginkgo Bioworks Holdings | December 20 Price is up by 6.5% in the last 24h. |
|
Ginkgo Bioworks Holdings | December 18 Price is down by -5.5% in the last 24h. |
|
Ginkgo Bioworks Holdings | December 16 AI Score is down by 22.5% in the last couple of days. |
|
Ginkgo Bioworks Holdings | December 16 Price is up by 5.6% in the last 24h. |
Alternative Data for Ginkgo Bioworks Holdings
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 2 | Sign up | Sign up | Sign up |
| Sentiment | 67 | Sign up | Sign up | Sign up |
| Webpage traffic | 45,000 | Sign up | Sign up | Sign up |
| Employee Rating | 62 | Sign up | Sign up | Sign up |
| Google Trends | N/A | Sign up | Sign up | Sign up |
| Patents | N/A | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Facebook Engagement | 26 | Sign up | Sign up | Sign up |
| Facebook Followers | 4,033 | Sign up | Sign up | Sign up |
| Instagram Followers | 12,409 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 41 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 12,957 | Sign up | Sign up | Sign up |
| Twitter Followers | 34,205 | Sign up | Sign up | Sign up |
| Twitter Mentions | 64 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 11 | Sign up | Sign up | Sign up |
| Linkedin Employees | 1,039 | Sign up | Sign up | Sign up |
About Ginkgo Bioworks Holdings
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming.
| Price | $10.08 |
| Target Price | Sign up |
| Volume | 3,320,000 |
| Market Cap | $502M |
| Year Range | $5.36 - $40.4 |
| Dividend Yield | 0% |
| Analyst Rating | 33% buy |
| Industry | Biotechnology |
In the news
 |
Head-To-Head Contrast: Ginkgo Bioworks (NYSE:DNA) and Cidara Therapeutics (NASDAQ:CDTX)December 19 - ETF Daily News |
 |
All You Need to Know About Ginkgo Bioworks (DNA) Rating Upgrade to BuyDecember 17 - Yahoo |
|
Janus Henderson Group PLC Decreases Stock Holdings in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)December 16 - ETF Daily News |
|
Zurcher Kantonalbank Zurich Cantonalbank Sells 144,336 Shares of Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)December 10 - ETF Daily News |
|
Verition Fund Management LLC Makes New Investment in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA)December 10 - ETF Daily News |
|
Stock Traders Buy Large Volume of Call Options on Ginkgo Bioworks (NYSE:DNA)December 5 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 88M | 60M | 28M | -56M | -38M | -1.080 |
| Q2 '24 | 56M | 136M | -80M | -217M | -206M | -4.400 |
| Q1 '24 | 50M | 83M | -34M | -166M | -165M | -0.080 |
| Q4 '23 | 8.7M | 102M | -93M | -212M | -165M | -0.110 |
| Q3 '23 | 70M | 182M | -112M | -303M | -265M | -0.160 |
Insider Transactions View All
| Dmytruk Mark E. filed to sell 32,386 shares at $9.6. December 5 '24 |
| Coen Steven P. filed to sell 6,869 shares at $9.6. December 5 '24 |
| Coen Steven P. filed to sell 6,046 shares at $8.4. October 8 '24 |
| Dmytruk Mark E. filed to sell 30,237 shares at $8.4. October 8 '24 |
| Coen Steven P. filed to sell 5,609 shares at $6.2. September 16 '24 |
Similar companies
Read more about Ginkgo Bioworks Holdings (DNA) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, facebook engagement, facebook followers, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Ginkgo Bioworks Holdings?
The Market Cap of Ginkgo Bioworks Holdings is $502M.
What is the current stock price of Ginkgo Bioworks Holdings?
Currently, the price of one share of Ginkgo Bioworks Holdings stock is $10.08.
How can I analyze the DNA stock price chart for investment decisions?
The DNA stock price chart above provides a comprehensive visual representation of Ginkgo Bioworks Holdings' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Ginkgo Bioworks Holdings shares. Our platform offers an up-to-date DNA stock price chart, along with technical data analysis and alternative data insights.
Does DNA offer dividends to its shareholders?
As of our latest update, Ginkgo Bioworks Holdings (DNA) does not offer dividends to its shareholders. Investors interested in Ginkgo Bioworks Holdings should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Ginkgo Bioworks Holdings?
Some of the similar stocks of Ginkgo Bioworks Holdings are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.